荷莫哈林顿因对SARS-CoV-2非常有效:在未来的冠状病毒流行中,它是潜在的第一线防御
Hai-Jun Wen1, Hua-Juan Ma2, Gong-Xun Zhong3
1State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.
National science review
|December 1, 2025
概括
霍莫哈林顿因 (HHT) 鼻喷雾有效地在2至4天内从上呼吸道清除SARS-CoV-2. 这种有前途的COVID-19治疗方法显示出广泛的冠状病毒潜力,在临床试验中没有观察到任何不良影响.
科学领域:
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- COVID-19代表了本世纪的第三次冠状病毒流行,需要为未来的爆发采取积极的治疗策略.
- 上呼吸道 (URT) 是SARS-CoV-2初始度和复制的主要位置.
- 现有的COVID-19治疗方法有局限性,突出了需要新的治疗方法的需要.
研究的目的:
- 为了研究同型关素 (HHT) 作为SARS-CoV-2感染的潜在治疗方法的疗效.
- 评估HHT在从上呼吸道清除病毒的有效性.
- 在临床前和临床环境中评估HHT的安全性和耐受性.
主要方法:
- 在体外研究评估HHT对冠状病毒复制的影响.
- 使用小鼠进行动物模型研究,以评估HHT的抗病毒活性 in vivo.
- 两项临床试验通过雾化和鼻喷剂给患有不同疾病的患者注射HHT.
主要成果:
- 在纳米分子度下,HHT在体外证明了SARS-CoV-2复制的强有力的抑制.
- 在小鼠中,HHT治疗导致病毒在3天内完全清除.
- 临床试验显示,大多数患者在几个小时内URT显著降低病毒载量,在2-4天内病毒清除,没有任何不良影响.
- 与传统的恢复时间相比,HHT治疗的持续时间明显较短.
结论:
- 荷莫哈林顿因 (HHT) 是SARS-CoV-2的高度有效和安全的治疗选择,可以迅速从上呼吸道清除病毒.
- HHT对多种冠状病毒表现出广泛的活性,这表明它在未来的冠状病毒流行中具有实用性.
- HHT的有利形象表明它有可能成为对新出现的冠状病毒威胁的第一线防御.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


